Stereotaxis (STXS) Shares Outstanding (Diluted Average) (2015 - 2026)
Stereotaxis (STXS) reported Shares Outstanding (Diluted Average) of $98.9 million for Q1 2026, up 12.67% year-over-year from $87.8 million in Q1 2025, and up 8.72% on a QoQ basis from $91.0 million in Q4 2025.
Stereotaxis (STXS) has 12 years of Shares Outstanding (Diluted Average) data on file, last reported at $98.9 million in Q1 2026.
- Quarterly Shares Outstanding (Diluted Average) rose 12.67% year-over-year to $98.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98.9 million (up 12.67% YoY) and the FY2025 annual result came in at $91.0 million, up 6.78% from the prior year.
- Shares Outstanding (Diluted Average) advanced to $98.9 million in Q1 2026 per STXS's latest filing, from $91.0 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $98.9 million in Q1 2026 and bottomed at $75.9 million in Q1 2022.
- The 5-year median for Shares Outstanding (Diluted Average) is $83.5 million (2024), against an average of $83.6 million.
- The widest annual swing landed in 2022, when Shares Outstanding (Diluted Average) grew 0.54%; it then climbed 12.67% in 2026.
- Tracing STXS's Shares Outstanding (Diluted Average) over 5 years: stood at $76.1 million in 2022, then rose by 6.1% to $80.7 million in 2023, then grew by 5.55% to $85.2 million in 2024, then climbed by 6.78% to $91.0 million in 2025, then rose by 8.72% to $98.9 million in 2026.
- Per Business Quant, the three latest STXS Shares Outstanding (Diluted Average) figures stand at $98.9 million (Q1 2026), $91.0 million (Q4 2025), and $92.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn | 359.80 Mn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn | - |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn | 145.72 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn | 72.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn | 175.50 Mn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn | 196.70 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn | 71.61 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn | 515.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn | 64.83 Mn |
| 10 | Stereotaxis | 187.40 Mn | 172.78 Mn | 3.79 Mn | 98.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.89 Mn |
| Dec 31, 2025 | 90.96 Mn |
| Sep 30, 2025 | 92.01 Mn |
| Jun 30, 2025 | 87.86 Mn |
| Mar 31, 2025 | 87.77 Mn |
| Dec 31, 2024 | 85.18 Mn |
| Sep 30, 2024 | 85.82 Mn |
| Jun 30, 2024 | 84.57 Mn |
| Mar 31, 2024 | 83.48 Mn |
| Dec 31, 2023 | 80.70 Mn |
| Sep 30, 2023 | 82.47 Mn |
| Jun 30, 2023 | 81.05 Mn |
| Mar 31, 2023 | 76.50 Mn |
| Dec 31, 2022 | 76.06 Mn |
| Sep 30, 2022 | 75.98 Mn |
| Jun 30, 2022 | 75.95 Mn |
| Mar 31, 2022 | 75.88 Mn |
| Dec 31, 2021 | 75.56 Mn |
| Sep 30, 2021 | 75.48 Mn |
| Jun 30, 2021 | 75.55 Mn |
| Mar 31, 2021 | 75.18 Mn |
| Dec 31, 2020 | 72.75 Mn |
| Sep 30, 2020 | 72.00 Mn |
| Jun 30, 2020 | 70.75 Mn |
| Mar 31, 2020 | 69.87 Mn |
| Dec 31, 2019 | 63.05 Mn |
| Sep 30, 2019 | 61.41 Mn |
| Jun 30, 2019 | 59.94 Mn |
| Mar 31, 2019 | 59.20 Mn |
| Dec 31, 2018 | 52.08 Mn |
| Sep 30, 2018 | 59.01 Mn |
| Jun 30, 2018 | 58.93 Mn |
| Mar 31, 2018 | 33.12 Mn |
| Dec 31, 2017 | 22.61 Mn |
| Sep 30, 2017 | 22.55 Mn |
| Jun 30, 2017 | 22.58 Mn |
| Mar 31, 2017 | 22.33 Mn |
| Dec 31, 2016 | 21.81 Mn |
| Sep 30, 2016 | 21.87 Mn |
| Jun 30, 2016 | 21.79 Mn |
| Mar 31, 2016 | 21.61 Mn |
| Dec 31, 2015 | 21.11 Mn |
| Sep 30, 2015 | 21.14 Mn |
| Jun 30, 2015 | 21.01 Mn |
| Mar 31, 2015 | 20.74 Mn |